Population pharmacokinetics and dose optimization of voriconazole in patients with COVID-19-associated pulmonary aspergillosis
This study provides an evidence-based guide for voriconazole dosing adjustments in CAPA patients, particularly for those undergoing CRRT. The findings emphasize the importance of individualized dosing to improve therapeutic outcomes in this high-risk population.
Authors
- Yue Shen (ORCID: https://orcid.org/0000-0001-5100-398X)
- Huaijun Zhu
- Hui Wang (ORCID: https://orcid.org/0000-0003-3217-8340)
- Jing Wang
- Xuemei Luo
- Lu Jin (ORCID: https://orcid.org/0000-0003-2724-5406)
Institutions
- Nanjing Drum Tower Hospital (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.3389/fphar.2025.1554370
- Citations
- 7
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 9.77